BARCELONA, Spain, April 1, 2015 /PRNewswire/ -- Grifols, S.A.
("Grifols") (MCE: GRF), (MCE: GRF.P) and (NASDAQ: GRFS) announced
that it has filed its 2014 Annual Report on Form 20-F with the
United States Securities and Exchange Commission ("SEC") on
April 1, 2015. Grifols' Annual Report
on Form 20-F includes its audited financial statements for its
fiscal year ended December 31,
2014.
Form 20-F can be accessed electronically through the Grifols
website at
http://inversores.grifols.com/en/web/international/sec_filings. The
Form 20-F is also available on the SEC's website at
http://www.sec.gov.
Grifols will deliver, within a reasonable time after request, a
hard copy of the Form 20-F, including its complete audited
financial statements, free of charge, to any shareholder upon
request. To request a hard copy, shareholders may contact Grifols
by email at investors@grifols.com to the attention of Grifols'
Investor Relations, Re: 2014 Annual Report on Form 20-F.
About Grifols. 75th Anniversary of improving people's
health.
Grifols is a global healthcare company founded in 1940. In 2015
Grifols celebrates its 75th Anniversary of improving people's
health and well being through the development of life-saving plasma
medicines, diagnostics systems, and hospital pharmacy products.
The company is present in more than 100 countries worldwide and
is headquartered in Barcelona,
Spain. Grifols is a leader in plasma collection with a
network of 150 plasma donor centers in the U.S., and a leading
producer of plasma-derived biological medicines. The company also
provides a comprehensive range of transfusion medicine, hemostasis,
and immunoassay solutions for clinical laboratories, blood banks
and transfusion centers, and is a recognized leader in transfusion
medicine.
In 2014, sales exceeded Euro 3.3
billion ($4.4 billion) with a
headcount close to 14,000 employees. Grifols demonstrates its
commitment to advancing healthcare by allocating a significant
portion of its annual income to R&D.
The company's class A shares are listed on the Spanish Stock
Exchange, where they are part of the Ibex-35 (MCE: GRF). Its
non-voting class B shares are listed on the Mercado Continuo (MCE:
GRF.P) and on the U.S. NASDAQ via ADRs (NASDAQ: GRFS). For more
information visit www.grifols.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/grifols-2014-annual-report-on-form-20-f-filed-with-the-sec-on-april-1-2015-300059194.html
SOURCE Grifols